NightHawk Biosciences Provides Second Quarter 2022 Business Update

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

DURHAM, N.C., Aug. 10, 2022 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided strategic, financial, and operational updates for the second quarter ended June 30, 2022. Jeff Wolf, Chief Executive Officer of NightHawk, commented, “We continue to advance our evolution towards becoming a fully-integrated biopharmaceutical company via our subsidiary ecosystem. Specifically, we are on track to open the Scorpion San Antonio biologics manufacturing facility in Q3 and are actively progressing development efforts for our newly-announced commercial scale biomanufacturing facility in Manhattan, Kansas. We intend to provide a full suite of CDMO manufacturing and bioanalytic services to biopharmaceutical...

MaxCyte Reports Second Quarter and Half-Year 2022 Financial Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

45% Year-Over-Year Core Business Revenue Growth in Second Quarter 2022 Raises 2022 Core Revenue Growth Guidance to Approximately 30% ROCKVILLE, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced financial results for the second quarter and six months ended June 30, 2022. Second Quarter and Recent Highlights Total revenue of $9.6 million in the second quarter of 2022, an increase of 35% over the second quarter of 2021 driven by strong growth in the cell therapy market; core business revenues grew 45% led by revenue from cell therapy customers which increased...

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

REDWOOD CITY, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update, and reported financial results for the three and six months ended June 30, 2022. Second Quarter 2022 and Recent Corporate Highlights U.S. Food and Drug Administration (FDA) acknowledged that data from a proposed randomized withdrawal phase of Study C602 would have the potential to address its concerns regarding the adequacy of the overall efficacy data supportive of a New Drug Application (NDA) submission for DCCR. Study C602 is an ongoing open-label extension study comprised of patients who completed DESTINY PWS, an international, multi-center, randomized, double-blind, placebo-controlled...

ADMA Biologics Announces Second Quarter 2022 Financial Results and Provides Business Update

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

2Q2022 Total Revenues Were $33.9 Million, a 90% Y-o-Y Increase Grew 2Q2022 Gross Profit to $7.8 Million, Up 112% Over 1Q2022 Narrowed 2Q2022 Net Losses to $13.8 Million, a 45% Improvement Over 1Q2022 Full Year 2022 Total Revenues Expected to Exceed $130 Million Gross Margin Growth and Narrowing Net Losses Expected Throughout 2022 and Beyond Conference Call Scheduled for Today at 4:30 p.m. ET RAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2022 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics, today announced its second quarter 2022 financial results and provided a business update. “The second quarter of 2022 was another banner period of execution for ADMA Biologics,...

Chalice Brands Ltd. Announces Change of Auditor

Written by Customer Service on August 10, 2022. Posted in Public Companies.

PORTLAND, Ore., Aug. 10, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF) (the “Company” or “Chalice Brands”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces that it has changed its auditor to M&K CPAS, PLLC (“Successor Auditor”) from Baker Tilly US, LLP (“Former Auditor”) due to the delays in completing the Company’s 2021 fiscal audit. The Company has requested that the Former Auditor resign as the auditor of the Company effective August 10, 2022. The Board of Directors of the Company appointed the Successor Auditor as the Company’s auditor effective August 10, 2022, to be effective until the next Annual General Meeting of the Company. In accordance with National Instrument 51-102 – Continuous...

HPQ Silicon PUREVAP™ Pilot Plant Testing Process Is Advancing and on Schedule

Written by Customer Service on August 10, 2022. Posted in Public Companies.

MONTREAL, Aug. 10, 2022 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQX: HPQFF) (FRA: O08), an innovative silicon solutions and technology development company, would like to update shareholders on progress made to date by technology provider, PyroGenesis Canada Inc. (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), during the ongoing PUREVAP™ Quartz Reduction Reactor (QRR) pilot plant Research and Development phase. HPQ GEN3 PUREVAP™ QRR PILOT PLANT R&D TESTING PROGRAM ADVANCING ON SCHEDULE The GEN3 PUREVAP™ QRR Pilot plant is a first-of-its-kind, state of the art prototype comprised of multiple systems that must operate under harsh conditions and extremely high temperatures. All independent systems have been tested and are fully functional. The final stage of integration is now underway. Therefore, PyroGenesis...

Toll Brothers Announces Model Homes Now Open and Amenities Coming Soon to Regency at Folsom Ranch Community Near Sacramento, Calif.

Written by Customer Service on August 10, 2022. Posted in Public Companies.

New 55+ luxury resort-style community features stunning architectural and interior design; 18,000-square-foot community clubhouse is under construction and opening early 2023 Toll Brothers Regency at Folsom Ranch “Home buyers can explore our new model homes, now open at Regency at Folsom Ranch, and get inspired as they browse a variety of exquisite home designs and floor plan options to fit their lifestyle,” said Todd Callahan, Division President of Toll Brothers in Northern California. Toll Brothers Regency at Folsom Ranch The 15 model homes at Regency at Folsom Ranch by Toll Brothers in Sacramento County are now open, showcasing the community’s stunning architectural and interior design. The 18,000-square-foot community clubhouse is under construction and opening early 2023. FOLSOM, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE)...

Reflect Scientific Inc. Releases Second Quarter 2022 Financials

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

OREM, Utah, Aug. 10, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, today announced financial results for the second quarter of 2022. “The supply chain issues plaguing U.S industries have recently affected some of the Reflect products. Although we anticipated much of the shipping delays and parts availability, we were finally hit with some shortages. We have been diligently researching workarounds and replacements. I do not expect this situation to extend past the third quarter.” stated Mr. Kim Boyce, CEO of Reflect Scientific. The following unaudited table summarizes revenue, cost of goods sold, and operating expenses for the three months ended June 30, 2022 and 2021: Three Months Ended...

Exodus Reports Second Quarter 2022 Results

Written by Customer Service on August 10, 2022. Posted in Earnings Releases And Operating Results.

OMAHA, Neb., Aug. 10, 2022 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (tZERO: EXOD, Securitize Markets: EXOD) (OTC: EXOD) (“the Company” or “Exodus”), the leading self-custodial cryptocurrency software platform, today announced its fiscal 2022 results for the second quarter ended June 30, 2022. The Company reported second quarter revenue of $13.0 million, a decrease of 53% year-over-year from Q2 2021, in-line with market trends. Second Quarter 2022 Financial Highlights In USD millions, except percentages Q2 2022 Q2 2021 % Change H1 2022 H1 2021 % Change Revenue $ 13.0 $ 27.7 (53 %) $ 28.4 $ 51.3 (45 %) Total Cost of Revenues 7.1 6.0 18 % 14.3 9.5 51 % Operating Expenses 10.8 7.2 50 % 19.7 11.6 70 % Income / (Loss) from Operations1 (4.9 ) 14.5 (134 %) (5.6 ) 30.2 (119 %) Operating...

One World Universe, Inc. Announces Ameritrust is Approved to Work with NewRez

Written by Customer Service on August 10, 2022. Posted in Public Companies.

HUNTINGTON BEACH, CA, Aug. 10, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – One World Universe, Inc. (OTC: OWUV), a publicly traded company that invests in sports related businesses, distressed assets, business opportunities within emerging industries such as the Metaverse, and providing humanitarian efforts in over 185 countries; One World Universe Inc. announces Ameritrust is approved to work with NewRez. Ameritrust is approved to work with NewRez as a new “Delegated Conv, Non-Del FHA and broker TPO business”. “Being able to connect Ameritrust with major lenders like NewRez, will give us the capacity to service more of our troops and allow us exposure in additional states,’ stated Caren Currier, CEO of One World Universe. This is a big opportunity for Ameritrust and our shareholders. We look forward to obtaining more partnerships...

Day: August 10, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice